Reduced-Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once-Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma: A Phase II Study
Transplantation and Cellular Therapy · 2026-11 · 32 (11) · 1415.e1-1415.e5
DOI: 10.1016/j.jtct.2026.06.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation and Cellular Therapy, 2026-11. Verfasst von Carl Shultz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Osborn Hematopoietic Malignancy and Cellular Therapy Program, West Virginia University, Morgantown, West Virginia. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Osborn Hematopoietic Malignancy and Cellular Therapy Program, West Virginia University, Morgantown, West Virginia.
- Department of Internal Medicine, Charleston Area Medical Center, Charleston, West Virginia. Electronic address: shirodkar.sh@gmail.com.
- Divsion of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of W…
Zitieren
APA
Shultz, C., Shirodkar, S., Wakefield, C., Rollins, S., Wen, S., Ross, K., Craig, M., Cumpston, A., Hamadani, M., Kanate, A. S., & Veltri, L. (2026). Reduced-Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once-Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma: A Phase II Study. Transplantation and Cellular Therapy, 32(11), 1415.e1-1415.e5. https://doi.org/10.1016/j.jtct.2026.06.034
Vancouver
Shultz C, Shirodkar S, Wakefield C, Rollins S, Wen S, Ross K, et al. Reduced-Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once-Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma: A Phase II Study. Transplantation and Cellular Therapy. 2026;32(11):1415.e1-1415.e5. doi:10.1016/j.jtct.2026.06.034
BibTeX
@article{Shultz2026,
author = {Shultz, Carl and Shirodkar, Shreyas and Wakefield, Chelby and Rollins, Steven and Wen, Sijin and Ross, Kelly and Craig, Michael and Cumpston, Aaron and Hamadani, Mehdi and Kanate, Abraham S and Veltri, Lauren},
title = {Reduced-Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once-Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma: A Phase II Study},
journal = {Transplantation and Cellular Therapy},
year = {2026},
volume = {32},
number = {11},
pages = {1415.e1--1415.e5},
doi = {10.1016/j.jtct.2026.06.034}
}
EUVIMED